Haematology
- DISEASE INDICATIONS: Myelofibrosis
- MANUFACTURER: Impact Biomedicines, Inc.
- USAGE: Oral
- MEDICINE APPROVED BY:
- European Medical Agency (EMA)
- Food and Drug Administration (FDA)
Inrebic, with the generic name fedratinib, is a prescription medication used in the treatment of certain types of myelofibrosis, a rare bone marrow disorder.
$5,382.30
Select optionsThis product has multiple variants. The options may be chosen on the product page